Salt CompositionLidocaine (Lignocaine) 21.3mg
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Local anesthesia (Numb tissues in a specific area)
Customers also bought
More About Lignowin 21.3mg Injection
Benefits
In Local anesthesia (Numb tissues in a specific area) Lignowin 21.3mg Injection is a local anesthetic. It makes your skin numb. It works by blocking nerve signals in your body. It is generally very safe, works quite quickly, and will reduce the discomfort that might be caused by invasive medical procedures such as surgery, needle punctures, or insertion of a catheter or breathing tube.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How it works
Lignowin 21.3mg Injection is a local anesthetic. It works by blocking the transmission of pain signals from the nerves to the brain. This helps to decrease the sensation of pain.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Lignowin 21.3mg Injection .
Safe when prescribed by an expert: Lignowin 21.3mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Safe when prescribed by an expert: Lignowin 21.3mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
SAFE - Lignowin 21.3mg Injection does not usually affect your ability to drive.
Caution Advised: Lignowin 21.3mg Injection should be used with caution in patients with severe kidney disease. Dose adjustment of Lignowin 21.3mg Injection may be needed. Doctor consultation is advised.
Caution Advised: Lignowin 21.3mg Injection should be used with caution in patients with liver disease. Dose adjustment of Lignowin 21.3mg Injection may be needed. Doctor consultation is advised.
Manufacturer Address
near axis bank, amrawati road, wadi,nagpur-440 023 (maharashtra) india
References
Catterall WA, Mackie K. Local Anesthetics. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 572-73
Hume JR, Grant AO. Agents Used in Cardiac Arrhythmias. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 238-39
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 798-99
Lidocaine. Gloucester: Hameln Pharmaceuticals Ltd.; 2002 (05 Apr. 2019)
Lidocaine. Schaumburg, Illinois: APP Pharmaceuticals; 2010 (05 Apr. 2019)
Drugs.com. Lidocaine (05 Apr. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
